Merck (MRK) Market Capitalization (2009 - 2026)

Merck (MRK) has reported Market Capitalization for 18 consecutive years, with $317.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 60.34% year-over-year to $317.0 billion in Q2 2026; TTM through Jun 2026 was $317.0 billion, a 60.34% increase from a year earlier, with the FY2025 full-year figure at $260.2 billion, up 3.56% from the prior year.
• Market Capitalization was $317.0 billion for Q2 2026 at Merck, up from $297.1 billion in the prior quarter.
• Over five years, Market Capitalization peaked at $334.2 billion in Q1 2024 and troughed at $197.7 billion in Q2 2025.
• A 5-year average of $262.8 billion and a median of $265.4 billion in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization sank 36.99% in 2025 and surged 60.34% in 2026, its largest moves.
• Over 5 years, Market Capitalization stood at $281.7 billion in 2022, then fell by 1.97% to $276.1 billion in 2023, then decreased by 8.99% to $251.3 billion in 2024, then grew by 3.56% to $260.2 billion in 2025, then gained by 21.82% to $317.0 billion in 2026.
• The last three Market Capitalization figures came in at $317.0 billion (Q2 2026), $297.1 billion (Q1 2026), and $260.2 billion (Q4 2025), per Business Quant data.